Ranbaxy told to give pricing data info in US
MUMBAI (TIP): Indian generic drugmaker Ranbaxy Laboratories said on Wednesday that federal authorities in the United States had sought details on how it reports pricing data for some products eligible for reimbursement under the Medicaid […]
